Prescription drug · NDA
Dulera NDC 78206-126
mometasone furoate and formoterol fumarate dihydrate · Mometasone furoate 200 ug/1; Formoterol fumarate 5 ug/1 · Aerosol · Respiratory (Inhalation) · Organon LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 78206-126-01 | 78206012601 | 1 CANISTER in 1 CARTON (78206-126-01) / 120 AEROSOL in 1 CANISTERMarketed from Jun 1, 2021 | |
| 78206-126-02 | 78206012602 | 1 CANISTER in 1 CARTON (78206-126-02) / 60 AEROSOL in 1 CANISTERMarketed from Jun 1, 2021 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Dulera
- Generic name (nonproprietary)
- mometasone furoate and formoterol fumarate dihydrate
- Active ingredients
- Mometasone furoate — 200 ug/1Formoterol fumarate — 5 ug/1
- Dosage form
- Aerosol
- Route
- Respiratory (Inhalation)
- Labeler
- Organon LLC
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 022518
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic beta2-Agonists (Mechanism)Corticosteroid Hormone Receptor Agonists (Mechanism)Corticosteroid Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 78206-126_8acf5435-9cbf-4991-b7ef-5e5e7d61220aSPL ID 8acf5435-9cbf-4991-b7ef-5e5e7d61220aSPL set ID 8f399784-f257-4f31-b3dc-368bf2a1864dRxCUI 1246308, 1246310, 1246311, 1246313, 1660933, 1660934, 1660937, 1660938, 2196590, 2196592UNII 04201GDN4R, W34SHF8J2K
- Pharmacologic class
- Corticosteroid; beta2-Adrenergic Agonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N478206012601followed by a unit qualifier and the quantityPackage 78206-0126-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
DULERA is a combination product containing a corticosteroid and a long-acting beta 2 -adrenergic agonist (LABA) indicated for: Treatment of asthma in patients 5 years of age and older. ( 1.1 ) Important Limitation of Use: Not indicated for the relief of acute bronchospasm. ( 1.1 ) 1.1 Treatment of Asthma DULERA is indicated for the twice-daily treatment of asthma in patients 5 years of age and older. DULERA should be used for patients not adequately controlled on a long-term asthma-control medication such as an inhaled corticosteroid (ICS) or whose disease warrants initiation of treatment with both an ICS and long-acting beta 2 -adrenergic agonist (LABA). Important Limitation of Use: DULERA …
Excerpt only. Read the full label for complete information.
Other NDCs under NDA 022518
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Duleramometasone furoate and formoterol fumarate dihydrate | Mometasone furoate 50 ug/1; Formoterol fumarate 5 ug/1 | AerosolRespiratory (Inhalation) | Organon LLC | 78206-125 |
| Duleramometasone furoate and formoterol fumarate dihydrate | Mometasone furoate 100 ug/1; Formoterol fumarate 5 ug/1 | AerosolRespiratory (Inhalation) | Organon LLC | 78206-127 |